PIAS3 and breast carcinoma: Quantitative analyses of the proportion of MDA-MB-231 breast cancer cell-derived organoids showing an invasive behavior revealed that expression of PIAS3 shRNA-1 and PIAS3 shRNA-2 alone or together led to 65% increase in the number of breast cancer cell-derived organoids with invasive growth (Figure 3D).